Wednesday, May 22, 2024
HomeTags.COV2.S

.COV2.S

Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses

Johnson & Johnson (the Company) announced preliminary results from an independent study, including a subset of participants from the Janssen-sponsored COV2008 study, conducted by...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics